Medications

Second Interim Analysis of Clinical Trial Data Showed a 91.4% Efficacy for the Sputnik V Vaccine on Day 28 After the First Dose; Vaccine Efficacy is Over 95% 42 days After the First Dose

The efficacy of the Sputnik V vaccine is 91.4%, based on the second interim analysis of data obtained 28 days after administering the first dose (7 days after the second dose). Calculation was based on the analysis of data on volunteers (n = 18,794) who received both the first and second doses of the Sputnik […]

Medications

Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Evidence of Efficacy in First Interim Analysis from Phase 3 Study

NEW YORK & MAINZ, GERMANY–(BUSINESS WIRE) November 9, 2020 Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Analysis evaluated 94 confirmed cases of COVID-19 in trial participants Study enrolled 43,538 participants, with 42% having diverse backgrounds, […]

Health News

Here’s how a COVID-19 vaccine would actually work

We’ve been wearing masks and socially distancing for months now because of the coronavirus, but an end in sight came a step closer. U.S. drug company Pfizer and German partner BioNTech SE announced that early analysis of their Covid-19 vaccine shows it is more than 90 percent effective at infection prevention (via NBC News).  Dr […]

Health News

Russia registers new Covid vaccine as cases hit record high

Credit: Pixabay/CC0 Public Domain President Vladimir Putin announced on Wednesday that Russia has registered its second coronavirus vaccine, while the country reported a record number of new infections. “The Novosibirsk Vektor centre today registered the second Russian vaccine against coronavirus—EpiVacCorona,” Putin said during a video conference with cabinet members. Vektor, a top-secret laboratory in the […]

Health News

Extra safety scrutiny planned as virus vaccine worries grow

Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning extra scrutiny of the first people vaccinated when shots become available—an added safety layer experts call vital. A new poll suggests those vaccine fears are growing. With this week’s pause of a second major vaccine study because of an unexplained illness—and repeated tweets […]